Research is finding ways to extend animal lifespans but regulators are still wary of treating ageing as a disease

With revenues having more than doubled since 2019, to $10bn, US pharma group targets painkillers

Biosecure Act would prohibit American companies receiving federal grant money from working with some Chinese groups

Continent’s drugmakers need to pay up to attract and retain talent, says Pascal Soriot

Success of biosimilars in lowering prices will depend on decisions from powerful pharmacy benefit managers

Neglecting women’s pain affects the entire medical pipeline, from research to diagnosis and treatment